Never-smokers exposed to high levels of fine particulate air pollution have a significantly greater risk of developing lung cancer, according to a study published July 2 in Nature by the University of California San Diego and the National Cancer Institute.

Fact checked by Jennifer Klump Although a lot fewer people are smoking cigarettes, lung cancer is still the leading cause of cancer-related deaths in the United States. Recent research has found that lung cancer is rising among people who have never smoked,

Rates of the world's deadliest cancer appear to be low in sub-Saharan Africa. But that statistic is masking the scope of the disease, doctors say.

Dean Comstock was 27 when he received the frightening diagnosis of terminal lung cancer. The singer and runner had never smoked. Doctors told him he could live up to three years through chemotherapy,

A research team has developed a nanobody-based technology that can precisely identify and attack only lung cancer cells, opening new possibilities for cancer therapy.

Following the June 2025 FDA approval of Datroway, Dr. Jacob A. Sands explained the significance of the regulatory approval for patients with lung cancer.

Ultra-processed foods have been linked to a slew of health conditions, including obesity, type 2 diabetes, and cardiovascular disease. But new research suggests a surprising association between ultra-processed foods and lung cancer, raising all kinds of questions in the process.

ASHLAND UK King’s Daughters announced it is offering the Ion Endoluminal System, a robotic-assisted platform that provides a safer, more precise and minimally invasive way to biopsy lung nodules, according to a news release.

With the FDA approval of its zongertinib in certain non-small cell lung cancer (NSCLC) patients, 175-year-old Boehringer Ingelheim is entering the oncology market. | Zongertinib got an accelerated approval for previously treated non-small cell lung cancer patients who have the relatively rare HER2 tyrosine kinase domain-activating mutations.

A Nevada mother of four shares how biomarker testing and precision medicine are helping her beat the odds against lung cancer, as doctors call the approach a "game changer" in treatment.